Erasca, Inc.
ERAS
$18.38
$0.522.91%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/16/2026
-
MarketBeat
8/15/2026
-
Tickeron - Stocks
8/14/2026
-
The Cerbat Gem
8/14/2026
-
MarketBeat
8/14/2026
-
Globe Newswire
8/14/2026
-
MarketBeat
8/14/2026
-
TipRanks
8/14/2026
-
TipRanks
8/14/2026
-
MarketBeat
8/13/2026
-
Tickeron - Stocks
8/12/2026
-
Zacks Investment Research
8/12/2026
-
The Cerbat Gem
8/12/2026
-
MarketBeat
8/12/2026
-
Tickeron - Stocks
8/12/2026
-
MarketBeat
8/11/2026
-
MarketBeat
8/11/2026
-
Seeking Alpha - Healthcare
8/11/2026
-
TipRanks: TheFly
8/11/2026
-
Globe Newswire
8/11/2026
-
Simply Wall St
8/11/2026
-
MarketBeat
8/10/2026
-
TipRanks
8/10/2026
-
GuruFocus
8/10/2026
-
Business Wire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, August 11, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 465 6511
Address
3115 Merryfield Row
Suite 300
San Diego, CA 92121
Suite 300
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company’s...
more